However, none of the tested compounds induced apoptosis in HNSCC cells, even after prolonged treatment (72 h) at a higher concentration (1 μM), as evaluated by TUNEL assay or by Western blot analyses for cleaved caspase-3 and PARP cleavage. The gene discussed is CASP3; the disease is head and neck squamous cell carcinoma.